Cluster: Health Economy

Novartis begins construction of new research centre in San Diego, US

Novartis: new global biomedical research centre opens in San Diego

This content was published on Feb 9, 2026 Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees.

Medicines: sales increase by 5% in Switzerland in 2025

Drug pricing

Swiss medicine revenues pegged back by price reductions

This content was published on Feb 7, 2026 Swiss pharma market records CHF8.1 billion revenues at factory prices in 2025.

New treatments

Science podcast: the story behind the ‘longevity pill’ rapamycin

This content was published on Feb 6, 2026 In episode 5 of this season's Swiss Connection science podcast, we talk about the discovery of TOR and its potential for longevity.

Medicine access

First Alzheimer’s drug authorised in Switzerland

This content was published on Feb 4, 2026 Swissmedic authorises first drug to slow down the progression of Alzheimer's disease.

Healthcare innovation

Going global: Weleda’s new CEO wants to put the cosmetics company on the map

This content was published on Jan 31, 2026 Weleda CEO Tina Müller talks about the quiet revolution she initiated at the Swiss cosmetics and healthcare company.

AI and medicine

How AI is used in diagnostics

This content was published on Jan 30, 2026 Medical experts now use artificial intelligence to help them diagnose and monitor diseases. But does this mean AI will replace doctors?

AI and medicine

From London to Lausanne: how Isomorphic Labs is rewriting drug discovery

This content was published on Jan 30, 2026 Google DeepMind spin-off Isomorphic Labs is expanding in Switzerland to achieve its ambitious goal to "solve all diseases" with AI.

New treatments

Science podcast: the AI revolution in drug development

This content was published on Jan 30, 2026 In episode 4 of the Swiss Connection Science podcast we explore the role of AI in drug development.

Roche achieves research success with novel fat-lowering agent

New treatments

Roche reports positive results for experimental obesity drug

This content was published on Jan 27, 2026 Roche says that a phase II clinical trial of its experimental obesity drug CT-388 has given positive results.

New treatments

Science podcast: Can gender diversity create better medicine?

This content was published on Jan 23, 2026 In episode 3 of this season's Swiss Connection science podcast we look at the role of sex and gender in drug development.

Cluster: Health Economy

Popular Stories

Most Discussed

Cluster: Health Economy

More

Novartis begins construction of new research centre in San Diego, US

More

Swiss medicine revenues pegged back by price reductions

More

Science podcast: the story behind the ‘longevity pill’ rapamycin

More

First Alzheimer’s drug authorised in Switzerland

More

Going global: Weleda’s new CEO wants to put the cosmetics company on the map

More

How AI is used in diagnostics

More

From London to Lausanne: how Isomorphic Labs is rewriting drug discovery

More

Science podcast: the AI revolution in drug development

More

Roche reports positive results for experimental obesity drug

More

Science podcast: Can gender diversity create better medicine?

Popular Stories

Most Discussed